These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30991446)

  • 21. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
    Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
    Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
    Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An Overview of NAFLD/NASH in Japan].
    Kim SR; Kim KI
    Yakugaku Zasshi; 2016; 136(4):565-72. PubMed ID: 27040340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis.
    Bazerbachi F; Vargas EJ; Rizk M; Maselli DB; Mounajjed T; Venkatesh SK; Watt KD; Port JD; Basu R; Acosta A; Hanouneh I; Gara N; Shah M; Mundi M; Clark M; Grothe K; Storm AC; Levy MJ; Abu Dayyeh BK
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):146-154.e4. PubMed ID: 32360804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score.
    Tan CH; Al-Kalifah N; Ser KH; Lee YC; Chen JC; Lee WJ
    Surg Obes Relat Dis; 2018 Oct; 14(10):1600-1606. PubMed ID: 30077664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.
    Vilar-Gomez E; Yasells-Garcia A; Martinez-Perez Y; Calzadilla-Bertot L; Torres-Gonzalez A; Gra-Oramas B; Gonzalez-Fabian L; Villa-Jimenez O; Friedman SL; Diago M; Romero-Gomez M
    Hepatology; 2016 Jun; 63(6):1875-87. PubMed ID: 26849287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.
    Ahmed A; Wong RJ; Harrison SA
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2062-70. PubMed ID: 26226097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
    Xanthakos SA; Lavine JE; Yates KP; Schwimmer JB; Molleston JP; Rosenthal P; Murray KF; Vos MB; Jain AK; Scheimann AO; Miloh T; Fishbein M; Behling CA; Brunt EM; Sanyal AJ; Tonascia J;
    Gastroenterology; 2020 Nov; 159(5):1731-1751.e10. PubMed ID: 32712103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease: Synopsis of current developments.
    Onyekwere CA; Ogbera AO; Samaila AA; Balogun BO; Abdulkareem FB
    Niger J Clin Pract; 2015; 18(6):703-12. PubMed ID: 26289505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological Endpoints for Nonalcoholic Steatohepatitis Trials: Lights and Shadows.
    Rowe IA
    Semin Liver Dis; 2020 Nov; 40(4):339-345. PubMed ID: 32906165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of patients with non-alcoholic steatohepatitis (NASH) in real life.
    Serfaty L
    Liver Int; 2018 Feb; 38 Suppl 1():52-55. PubMed ID: 29427486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive lifestyle intervention
    Deibert P; Lazaro A; Schaffner D; Berg A; Koenig D; Kreisel W; Baumstark MW; Steinmann D; Buechert M; Lange T
    World J Gastroenterol; 2019 Mar; 25(9):1116-1131. PubMed ID: 30862999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial.
    Houghton D; Thoma C; Hallsworth K; Cassidy S; Hardy T; Burt AD; Tiniakos D; Hollingsworth KG; Taylor R; Day CP; McPherson S; Anstee QM; Trenell MI
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):96-102.e3. PubMed ID: 27521509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State of the art: treatment of nonalcoholic steatohepatitis.
    Pearlman M; Loomba R
    Curr Opin Gastroenterol; 2014 May; 30(3):223-37. PubMed ID: 24717764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review.
    Schattenberg JM; Anstee QM; Caussy C; Bugianesi E; Popovic B
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1253-1266. PubMed ID: 34493137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: the management of paediatric nonalcoholic fatty liver disease.
    Mitchel EB; Lavine JE
    Aliment Pharmacol Ther; 2014 Nov; 40(10):1155-70. PubMed ID: 25267322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity.
    Tai CM; Yu ML; Tu HP; Huang CK; Hwang JC; Chuang WL
    Surg Obes Relat Dis; 2017 Apr; 13(4):686-692. PubMed ID: 28089433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
    Nan YM; Fu N; Li WC; Kong LL; Yuan XW; Zhang SY; Liu LD; Lu Y; Cui LY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):687-694. PubMed ID: 29108191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.